Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Jan-23 5:06 PM View:  | Nau Jeffrey President and CEO Director | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition | 1,000 | -- | -- | (< 1%) 101.74K to 100.74K | |
| 04-Jan-23 6:11 PM View: | Versant Venture Capital Vi,... 10% Owner | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition (change in control) | 2,236,890 | -- | -- | (61%) 3.66M to 1.42M | |
| 04-Jan-23 5:02 PM View: | Atieh Michael G Director | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition | 8,671 | -- | -- | (32%) 26.73K to 18.06K | |
| 04-Jan-23 5:07 PM View: | Clare Ozawa Director | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition (change in control) | 3,657,620 | -- | -- | (100%) 3.66M to 0 | |
| 04-Jan-23 5:06 PM View: | Nau Jeffrey President and CEO Director | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition (change in control) | 100,738 | -- | -- | (100%) 100.74K to 0 | |
| 05-Jan-23 4:30 PM View: | Invopps Gp Iv, L.L.C. Director 10% Owner | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition (change in control) | 2,768,590 | -- | -- | (100%) 2.77M to 0 | |
| 04-Jan-23 5:03 PM View: | Eliades George Christopher Director | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition | 28,624 | -- | -- | (100%) 28.62K to 0 | |
| 04-Jan-23 5:05 PM View: | Murray Mark Anthony Director | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition | 122,086 | -- | -- | (100%) 122.09K to 0 | |
| 04-Jan-23 5:08 PM View: | Tsai Benjamin Director | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition | 3,573 | -- | -- | (26%) 13.64K to 10.07K | |
| 04-Jan-23 6:11 PM View: | Versant Venture Capital Vi,... 10% Owner | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition (change in control) | 1,420,730 | -- | -- | (100%) 1.42M to 0 | |
| 04-Jan-23 5:02 PM View: | Atieh Michael G Director | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition (change in control) | 18,063 | -- | -- | (100%) 18.06K to 0 | |
| 04-Jan-23 5:10 PM View: | Weisner Aimee S Director | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition | 36,764 | -- | -- | (100%) 36.76K to 0 | |
| 04-Jan-23 5:04 PM View: | Lochner Daniel Chief Financial Officer | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition | 20,236 | -- | -- | (26%) 76.53K to 56.29K | |
| 04-Jan-23 5:04 PM View: | Lochner Daniel Chief Financial Officer | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition (change in control) | 56,289 | -- | -- | (100%) 56.29K to 0 | |
| 04-Jan-23 5:16 PM View: | Behbahani Ali Director | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition | 13,639 | -- | -- | (100%) 13.64K to 0 | |
| 04-Jan-23 5:14 PM View: | New Enterprise Associates 1... 10% Owner | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition (change in control) | 5,925,290 | -- | -- | (100%) 5.93M to 0 | |
| 04-Jan-23 5:08 PM View: | Santel Donald J Director | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition | 8,198 | -- | -- | (60%) 13.69K to 5.49K | |
| 04-Jan-23 5:06 PM View: | Nau Jeffrey President and CEO Director | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition | 47,975 | -- | -- | (32%) 149.71K to 101.74K | |
| 04-Jan-23 5:07 PM View: | Clare Ozawa Director | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition | 14,637 | -- | -- | (< 1%) 3.67M to 3.66M | |
| 04-Jan-23 5:08 PM View: | Tsai Benjamin Director | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition (change in control) | 10,066 | -- | -- | (100%) 10.07K to 0 | |
| 04-Jan-23 5:08 PM View: | Santel Donald J Director | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition (change in control) | 5,489 | -- | -- | (100%) 5.49K to 0 | |
| 05-Dec-22 5:36 PM View: | Nau Jeffrey President and CEO Director | Oyster Point Pharma, Inc. (OYST) | 01-Dec-22 | Payment of Exercise | 6,217 | $11.20 | $69,630.40 | (4%) 158.6K to 152.38K | |
| 06-Dec-22 8:50 AM View: | Lochner Daniel Chief Financial Officer | Oyster Point Pharma, Inc. (OYST) | 01-Dec-22 | Payment of Exercise | 3,258 | $11.20 | $36,489.60 | (4%) 77.72K to 74.46K | |
| 08-Jun-22 4:46 PM View: | Tsai Benjamin Director | Oyster Point Pharma, Inc. (OYST) | 06-Jun-22 | Grant | 3,573 | -- | -- | 35% 10.07K to 13.64K | |
| 08-Jun-22 4:47 PM View: | Weisner Aimee S Director | Oyster Point Pharma, Inc. (OYST) | 06-Jun-22 | Grant | 3,573 | -- | -- | 11% 33.19K to 36.76K | |
| 08-Jun-22 4:49 PM View: | Behbahani Ali Director | Oyster Point Pharma, Inc. (OYST) | 06-Jun-22 | Grant | 3,573 | -- | -- | 35% 10.07K to 13.64K | |
| 08-Jun-22 4:43 PM View: | Santel Donald J Director | Oyster Point Pharma, Inc. (OYST) | 06-Jun-22 | Grant | 3,573 | -- | -- | 35% 10.11K to 13.69K | |
| 08-Jun-22 4:49 PM View: | Clare Ozawa Director | Oyster Point Pharma, Inc. (OYST) | 06-Jun-22 | Grant | 3,573 | -- | -- | < 1% 3.67M to 3.67M | |
| 08-Jun-22 4:45 PM View: | Murray Mark Anthony Director | Oyster Point Pharma, Inc. (OYST) | 06-Jun-22 | Grant | 3,573 | -- | -- | 3% 118.51K to 122.09K | |
| 08-Jun-22 4:44 PM View: | Atieh Michael G Director | Oyster Point Pharma, Inc. (OYST) | 06-Jun-22 | Grant | 3,573 | -- | -- | 15% 23.16K to 26.73K | |
| 08-Jun-22 4:48 PM View: | Eliades George Christopher Director | Oyster Point Pharma, Inc. (OYST) | 06-Jun-22 | Grant | 3,573 | -- | -- | 14% 25.05K to 28.62K | |
| 04-Jan-23 5:04 PM View: | Lochner Daniel Chief Financial Officer | Oyster Point Pharma, Inc. (OYST) | 29-Jan-22 | Payment of Exercise | 938 | $11.70 | $10,974.60 | (1%) 77.46K to 76.53K | |
| 04-Jan-23 5:06 PM View: | Nau Jeffrey President and CEO Director | Oyster Point Pharma, Inc. (OYST) | 29-Jan-22 | Payment of Exercise | 2,607 | $11.70 | $30,501.90 | (2%) 152.32K to 149.71K | |
| 11-Jan-22 7:47 PM View: | Snisarenko John Chief Commercial Officer | Oyster Point Pharma, Inc. (OYST) | 09-Jan-22 | Grant | 12,100 | -- | -- | 66% 18.22K to 30.32K | |
| 11-Jan-22 7:46 PM View: | Nau Jeffrey President and CEO Director | Oyster Point Pharma, Inc. (OYST) | 09-Jan-22 | Grant | 46,700 | -- | -- | 42% 111.9K to 158.6K | |
| 11-Jan-22 7:45 PM View: | Lochner Daniel Chief Financial Officer | Oyster Point Pharma, Inc. (OYST) | 09-Jan-22 | Grant | 19,500 | -- | -- | 33% 58.22K to 77.72K | |
| 07-Jan-22 4:20 PM View: | Versant Venture Capital Vi,... 10% Owner | Oyster Point Pharma, Inc. (OYST) | 05-Jan-22 | Disposition (other) Duplicate | 51,556 | -- | -- | (1%) 3.91M to 3.86M | |
| 07-Jan-22 4:18 PM View: | Clare Ozawa Director 10% Owner | Oyster Point Pharma, Inc. (OYST) | 05-Jan-22 | Acquisition (other) | 120 | -- | -- | < 1% 3.92M to 3.92M | |
| 07-Jan-22 4:20 PM View: | Versant Venture Capital Vi,... 10% Owner | Oyster Point Pharma, Inc. (OYST) | 05-Jan-22 | Disposition (other) Duplicate | 201,474 | -- | -- | (5%) 3.86M to 3.66M | |
| 07-Jan-22 6:08 PM View: | Link William J Phd Director | Oyster Point Pharma, Inc. (OYST) | 05-Jan-22 | Acquisition (other) | 6,839 | -- | -- | 1% 483.8K to 490.63K | |
| 07-Jan-22 4:18 PM View: | Clare Ozawa Director 10% Owner | Oyster Point Pharma, Inc. (OYST) | 05-Jan-22 | Disposition (other) Duplicate | 51,556 | -- | -- | (1%) 3.92M to 3.87M | |
| 07-Jan-22 4:20 PM View: | Versant Venture Capital Vi,... 10% Owner | Oyster Point Pharma, Inc. (OYST) | 05-Jan-22 | Acquisition (other) Duplicate | 51,556 | -- | -- | 1% 3.86M to 3.91M | |
| 07-Jan-22 4:18 PM View: | Clare Ozawa Director 10% Owner | Oyster Point Pharma, Inc. (OYST) | 05-Jan-22 | Acquisition (other) | 51,556 | -- | -- | 1% 3.87M to 3.92M | |
| 07-Jan-22 4:18 PM View: | Clare Ozawa Director 10% Owner | Oyster Point Pharma, Inc. (OYST) | 05-Jan-22 | Disposition (other) | 201,474 | -- | -- | (5%) 3.87M to 3.67M | |
| 23-Dec-21 4:40 PM View: | Versant Venture Capital Vi,... 10% Owner | Oyster Point Pharma, Inc. (OYST) | 21-Dec-21 | Disposition (other) Duplicate | 51,556 | -- | -- | (1%) 4.11M to 4.06M | |
| 23-Dec-21 4:43 PM View: | Clare Ozawa Director 10% Owner | Oyster Point Pharma, Inc. (OYST) | 21-Dec-21 | Disposition (other) Duplicate | 51,556 | -- | -- | (1%) 4.12M to 4.07M | |
| 23-Dec-21 5:34 PM View: | Link William J Phd Director | Oyster Point Pharma, Inc. (OYST) | 21-Dec-21 | Acquisition (other) | 6,838 | -- | -- | 1% 678.43K to 685.27K | |
| 23-Dec-21 4:43 PM View: | Clare Ozawa Director 10% Owner | Oyster Point Pharma, Inc. (OYST) | 21-Dec-21 | Acquisition (other) Duplicate | 51,556 | -- | -- | 1% 4.07M to 4.12M | |
| 23-Dec-21 4:40 PM View: | Versant Venture Capital Vi,... 10% Owner | Oyster Point Pharma, Inc. (OYST) | 21-Dec-21 | Disposition (other) | 201,474 | -- | -- | (5%) 4.06M to 3.86M | |
| 23-Dec-21 4:43 PM View: | Clare Ozawa Director 10% Owner | Oyster Point Pharma, Inc. (OYST) | 21-Dec-21 | Disposition (other) Duplicate | 201,474 | -- | -- | (5%) 4.07M to 3.87M |
